1-9 of 9
Yun Jeong Oh
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-Term Assessment of Dasatinib-Induced Pulmonary Arterial Hypertension in Chronic Myeloid Leukemia

Jee Hyun Kong, Dr, Young-Woo Jeon, Sung-Eun Lee, Soo Young Choi, Soo-Hyun Kim, Yun Jeong Oh, Jin-Eok Park, Hye-Rim Jeon, Eun-Jung Jang, Suk Joong Oh, Dong-Wook Kim, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5535.
https://doi.org/10.1182/blood.V124.21.5535.5535
Published: 2014
Journal Articles

Distinct Associations Between UGT1A1 Gene Promoter Polymorphism and Hyperbilirubinemia in Korean CML Patients Treated with Nilotinib and Radotinib

Soo-Hyun Kim, Soo Young Choi, Sung-Eun Lee, Yun Jeong Oh, Hae Lyun Yoo, Eun-Jung Jang, Mi-yeon Choi, Moon-mi Jang, Hyeoung Joon Kim, MD, Jae-Yong Kwak, MD PhD, Hawk Kim, MD, PhD., Young-Rok Do, PhD, Dong-Wook Kim, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5511.
https://doi.org/10.1182/blood.V124.21.5511.5511
Published: 2014
Journal Articles

BCR-ABL1 Transcript of 7.93% at 3 Months Is an Early Predictor for Long-Term Survival to Second-Line Therapy Using Next Generation Tyrosine Kinase Inhibitors in Imatinib-Resistant Chronic Phase Chronic Myeloid Leukemia

Sung-Eun Lee, Soo Young Choi, Yun Jeong Oh, Soo-Hyun Kim, Hye-Young Song, Hea-Lyun Yoo, Mi-Young Lee, Moon-Jung Chae, Ki-Hoon Kang, Hee-Jeong Hwang, Eun-Jung Jang, Dong-Wook Kim, MD PhD
Journal: Blood
Blood (2014) 124 (21): 4564.
https://doi.org/10.1182/blood.V124.21.4564.4564
Published: 2014
Journal Articles

Efficacy of Nilotinib Vs High-Dose Imatinib Vs Sustaining Standard-Dose Imatinib in Early Chronic Phase CML Patients Who Have Suboptimal Molecular Response to Frontline Imatinib

Soo Young Choi, Sung-Eun Lee, Yun jeong Oh, Soo-Hyun Kim, Richard C. Woodman, Tomasz Szczudlo, MD, Saengsuree Jootar, MD, Hyeoung-Joon Kim, MD PhD, Sang Kyun Sohn, MD PhD, Joon Seong Park, MD, Sung-Hyun Kim, MD PhD, Dae-Young Zang, Suk-Joong Oh, Dong-Wook Kim, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1816.
https://doi.org/10.1182/blood.V124.21.1816.1816
Published: 2014
Journal Articles

Plasma Imatinib Trough Level Is a Predictor For 3-Month Early Molecular Response In New CP CML Patients

Sung-Eun Lee, M.D., Soo Young Choi, Soo-Hyun Kim, Yun Jeong Oh, Jin-Eok Park, Eun-Jung Jang, Dong-Wook Kim, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2716.
https://doi.org/10.1182/blood.V122.21.2716.2716
Published: 2013
Journal Articles

Kinetics Of Low-Level Mutant Clones Detected By Subcloning and Sequencing In Tyrosine Kinase Inhibitor Resistant CML

Soo-Hyun Kim, Soo Young Choi, Sung-Eun Lee, M.D., Yun Jeong Oh, Jin-Eok Park, Hae Lyun Yoo, Hye-Rim Jeon, Eun-Jung Jang, Dong-Wook Kim, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2720.
https://doi.org/10.1182/blood.V122.21.2720.2720
Published: 2013
Journal Articles

Predictive Factors For An Achievement Of 6-Month Early Molecular Response In New CP CML Patients Treated With Imatinib

Sung-Eun Lee, M.D., Soo Young Choi, Soo-Hyun Kim, Yun Jeong Oh, Jin-Eok Park, Eun-Jung Jang, Dong-Wook Kim, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5160.
https://doi.org/10.1182/blood.V122.21.5160.5160
Published: 2013
Journal Articles

Results From The Korean Imatinib Discontinuation Study (KIDS): Updated Data With 14-Month Median Follow Up

Yun jeong Oh, Soo Young Choi, Sung-Eun Lee, Soo-Hyun Kim, Hyeoung-Joon Kim, MD, PhD, Yeo-Kyeoung Kim, MD.PhD., Joon Seong Park, Seong Hyun Jeong, MD, Sung-Hyun Kim, MD, PhD, Dae Young Zang, Sukjoong Oh, Dong Hoe Koo, M.D, Hawk Kim, M.D., Young Rok Do, M.D., Jae-Yong Kwak, Jeong-A Kim, MD, PhD, Dae-Young Kim, Yeung-Chul Mun, Won Sik Lee, M.D., Myung Hee Chang, MD, Jinny Park, MD, PhD, Ho-Jin Shin, DongWook Kim
Journal: Blood
Blood (2013) 122 (21): 4003.
https://doi.org/10.1182/blood.V122.21.4003.4003
Published: 2013
Journal Articles

Nilotinib Or High-Dose Imatinib Compared With Standard-Dose Imatinib In Early Chronic Phase CML Patients Who Have Suboptimal Molecular Responses To Standard-Dose Imatinib: Including Updated Data From RE-Nice Study

Soo-Young Choi, Sung-Eun Lee, M.D., Yun Jeong Oh, Soo-Hyun Kim, Richard C. Woodman, Tomasz Szczudlo, Saengsuree Jootar, MD, Hyeoung-Joon Kim, MD, PhD, Sang Kyun Sohn, MD, PhD, Joon Seong Park, MD, Sung-Hyun Kim, MD, PhD, Dae-Young Zang, Suk-Joong Oh, Dong-Wook Kim, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1499.
https://doi.org/10.1182/blood.V122.21.1499.1499
Published: 2013